Icelanders, whose unusually low genetic variability makes them ideal for
studies on the origin of diseases, have agreed to reveal the secrets of their
genes to pharmaceuticals company Hoffmann-La Roche. The deal, worth $200
million, gives the company and its partner—deCode Genetics of
Reykjavik—exclusive rights to develop drugs from the genetic data of
Iceland’s population. In return, Icelanders will receive any resulting medicines
free.
More from 91av
Explore the latest news, articles and features
Technology
Flood of AI 'garbage' is pushing open-source developers to the limit
News
Life
A chromosome from a frozen rat has been resurrected inside mice
News
Mathematics
The maths meme that has been distracting mathematicians for a century
Comment
Mind
Becoming a parent may make you love your partner less
News
Popular articles
Trending 91av articles
1
Mysterious ‘cold blob’ in the Atlantic suggests the AMOC is weakening
2
Do turmeric and curcumin have any actual health benefits?
3
Why you need to future-proof your brain in middle age and how to start
4
Escher: The paradoxical artist beloved by mathematicians
5
Alice Roberts: 'We are fundamentally, at the end of the day, animals'
6
A golden age of maths is dawning and mathematicians are freaking out
7
Flood of AI 'garbage' is pushing open-source developers to the limit
8
The looming El Niño could be bad – but much worse is to come
9
The maths meme that has been distracting mathematicians for a century
10
Hearing loss is bad for the whole body – but new treatments are coming
